Hydroxychloroquine Politicization Continues as Ohio Board of Pharmacy Bans Drug & Then Rescinds

Hydroxychloroquine Politicization Continues as Ohio Board of Pharmacy Bans then

Only in the age of COVID-19 have drugs become so politicized. For example, the story of Hydroxychloroquine: drug that was promoted early on across the board as considered at least one early-stage option to attempt to treat the novel coronavirus. Some of the world’s largest studies, such as University of Oxford’s COPCOV, embraced the anti-malarial drug. But with the controversial Trump promotion as well as intense scrutiny on the data thereafter, came the emergence of medicinal “camps” and, of course, such polarization tends to produce the data that fits into the convenient paradigm or world view. Thereafter, a wave of data finding and evidence indicated the drug was either not safe or not effective. On the other hand, some studies evidenced real benefit, such the Henry Ford Healthcare system’s’ study suggesting it can reduce the death rate. Regardless, in today’s hyper-polarized and political world, investigational drug products can actually be associated with a movement, a cause, and even a political ideology. Now an Ohio Governor brings the Hydroxychloroquine conflict to the next level in Ohio; Mike DeWine, in response to a band on the drug by the Ohio Board of Pharmac...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee